Investments
10Portfolio Exits
1Service Providers
1About Devonshire Investors
Devonshire Investors is a private equity firm specializing in buyouts. The firm seeks to invest in information, communications, technology, telecom and managed services, energy, human resources outsourcing, human resources technology, healthcare, building supply, transportation and hospitality, pharmaceutical, natural resources, publishing, food and agriculture, medical and life sciences, and real estate. The firm seeks to invest in United States, Europe, North Africa, and Asia.

Want to inform investors similar to Devonshire Investors about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Latest Devonshire Investors News
Jun 19, 2023
15 June 2023, Los Angeles- Beekeeper’s Naturals revealed that a USD 14 million funding round, co-led by Devonshire Investors and CAVU Consumer Partners with participation from Vibrant Ventures and Muse Capital, had been completed. Devonshire Investors is a private investment business connected to FMR LLC, the parent company of Fidelity Investments. This comes after the 2020 Series B led by CAVU Consumer Partners for Beekeeper’s Naturals. This investment follows Beekeeper’s triple-digit YOY growth and retail expansion, which saw the company’s U.S. and Canadian site count rise from 5,000 to over 18,000 by 2022. The company’s quick expansion in retail and online will be supported by this cash, which will also help them build out their innovation pipeline. According to the company’s founder, Carly Stein Kremer, “Devonshire’s investment will support Beekeeper’s Naturals is taking another significant step towards revolutionizing the medicine cabinet and creating the most influential healthcare brand in the world.” “As we concentrate on retail expansion into 2024, we will continue to invest in brand marketing and product development.” With the help of a medical advisory board, goods developed by Beekeeper are still bridging the gap between healthcare and wellness. These products are founded on published research and clinical testing. Beekeeper’s Propolis Throat Spray, which has approximately 2 million bottles sold, is still a cult favorite for immune support, and celebrities like Lily Collins, Nas, and Cameron Diaz have invested in the company. “We are thrilled to be supporting Beekeeper’s Naturals as they accelerate their growth at retail and online,” said Suzanne Agnello, who oversaw the investment for Devonshire Investors. “The company’s propolis- and beehive-based medicines have a wide range of uses and are reshaping the OTC drug market. We believe there is a great chance the brand can keep growing quickly. Beekeeper’s Naturals, according to Jared Jacobs, Partner at CAVU Consumer Partners and Beekeeper’s Naturals Board member, “answers the call of modern consumers who demand cleaner, better-for-you, and effective alternatives to traditional OTC products.” We’re honored to work with Carly, Daniel, and the talented group they’ve put together to rethink the pharmacy aisle and create one of the most recognizable names in natural health and well-being. Beekeeper’s Naturals, a pioneer in the health and wellness market with products driven by propolis and supported by science, was founded by Carly Stein Kremer in 2017. The beekeeper-led team is dedicated to offering the cleanest, most effective therapies for contemporary health problems, such as chronic stress, restlessness, digestive problems, and sore throats. To ensure they are producing natural medicines that genuinely work, unlike other companies, they employ scientific rigor in their product development and commit to third-party pesticide testing. They prioritize people, plants, and propolis as a brand on a mission. We try our best to fact-check and bring well-researched as well as non-plagiarized content to you. Please let us know -if there are any discrepancies in any of our published stories, -how we can improve, -what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Devonshire Investors Investments
10 Investments
Devonshire Investors has made 10 investments. Their latest investment was in Pivotal Commware as part of their Series D on August 8, 2023.

Devonshire Investors Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
8/17/2023 | Series D | Pivotal Commware | $102M | No | 4 | |
6/16/2023 | Series C | Beekeeper's Naturals | $14M | Yes | 3 | |
5/4/2021 | Series D | Mainspring Energy | $95M | Yes | 10 | |
2/11/2021 | Series C | |||||
1/4/2021 | Series B |
Date | 8/17/2023 | 6/16/2023 | 5/4/2021 | 2/11/2021 | 1/4/2021 |
---|---|---|---|---|---|
Round | Series D | Series C | Series D | Series C | Series B |
Company | Pivotal Commware | Beekeeper's Naturals | Mainspring Energy | ||
Amount | $102M | $14M | $95M | ||
New? | No | Yes | Yes | ||
Co-Investors | |||||
Sources | 4 | 3 | 10 |
Devonshire Investors Portfolio Exits
1 Portfolio Exit
Devonshire Investors has 1 portfolio exit. Their latest portfolio exit was Iora Health on June 07, 2021.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
6/7/2021 | Acquired | 10 |
Date | 6/7/2021 |
---|---|
Exit | Acquired |
Companies | |
Valuation | |
Acquirer | |
Sources | 10 |
Devonshire Investors Acquisitions
1 Acquisition
Devonshire Investors acquired 1 company. Their latest acquisition was NovoEd on October 16, 2018.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
10/16/2018 | Series A | $2.04M | Acq - Fin | 3 |
Date | 10/16/2018 |
---|---|
Investment Stage | Series A |
Companies | |
Valuation | |
Total Funding | $2.04M |
Note | Acq - Fin |
Sources | 3 |
Devonshire Investors Service Providers
1 Service Provider
Devonshire Investors has 1 service provider relationship
Service Provider | Associated Rounds | Provider Type | Service Type |
---|---|---|---|
Counsel | General Counsel |
Service Provider | |
---|---|
Associated Rounds | |
Provider Type | Counsel |
Service Type | General Counsel |
Partnership data by VentureSource
Devonshire Investors Team
6 Team Members
Devonshire Investors has 6 team members, including current Managing Director, David Jegen.
Name | Work History | Title | Status |
---|---|---|---|
David Jegen | Managing Director | Current | |
Name | David Jegen | ||||
---|---|---|---|---|---|
Work History | |||||
Title | Managing Director | ||||
Status | Current |